Medinox, Fuso Pharmaceutical Industries Ltd. deal

Fuso received exclusive development and commercialization rights in Japan for Medinox's intravenous NOX-100 nitric oxide neutralizing therapeutic to treat sepsis, and for one additional indication. M...